Specialties:

Most Popular Reports:

Newest Reports:

Endovascular Coiling Market Assessment (United States) – Wave 2

A Survey of 51 Neurosurgery and Interventional Neuroradiology Physicians

October 2007

Deliverable: Survey with key findings.

Study Description:

Topic

Endovascular Coiling Market Assessment

Respondent Type

Physicians

Specialties Covered

Neurosurgery and Interventional Neuroradiology

Region

United States Only

Methodology

Online survey, self-administered via a Panel Intelligence website

Duration: 25 minutes

Size: 51 respondents from the United States

Fielding Dates: 11th October to 23rd October, 2007 (Wave 2)

                          22nd June to 16th July, 2007 (Wave 1)

Objectives:

To understand the current and future trends in the endovascular market, perceptions of various manufacturers and endovascular coils in the U.S.   Additionally to:

§    Understand the use of microcoil products

§    Compare overall perceptions of various manufacturers (of coiling or coiling related products)

§    Understand attitudes toward Micrus bare platinum coils, Cerecyte microcoil, EV3 Axium, and J&J Orbit

§    Evaluate the familiarity and impact of the Matrix and Platinum Science (MAPS) trial

§    Assess future trends in cerebral aneurysm procedures and future microcoil product usage

Companies and Products Mentioned in This Report: 

Company

Ticker Symbol

Product(s)

Boston Scientific

BSX

Matrix2 360 and GDC (Guglielmi) 360

Micrus Endovascular

MEND

Cerecyte Microcoil, Presidio Microcoil, MicruSphere Microcoil, HeliPaq Microcoil, HeliPaq SR Microcoil, InterPaq Microcoil and UltiPaq Microcoil

JNJ / Cordis

JNJ

Trufill DCS Orbit

Microvention / Terumo

TUO.MU

MicroPlex Complex (3D) Coils, MicroPlex Helical Coils, MicroPlex HyperSoft Coils, HydroCoils

EV3 / Micro Therapeutics

 

Nexus, NXT, Tetris

 

Inclusion Criteria and Respondent Demographics

Inclusion Criteria

 

§    US-based neurosurgeon or interventional neuroradiologist

§    Board certified in specialty

§    In practice between 2 and 30 years

§    Familiar with minimally invasive procedures for the treatment of cerebral aneurysms

§    Currently treat patients with cerebral aneurysms using endovascular coiling

 

Purchase this report Reports become free one year after the publication date.

 

> about us      > contact us
© Panel Intelligence, LLC. 1999-2008. All rights reserved.
A wholly owned subsidiary of MCF Corporation (NASDAQ: MERR)
Privacy Policy